Pharmaceutical giant Merck (USA) promises to make its drug for the treatment of coronavirus available to rich and poor countries, while ensuring simultaneous supplies. The company’s director of global strategy Paul Sapper told AFP that Merck began developing the access policy back in the summer of 2020, pending results on the effectiveness of the tablets: […]